Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B - PubMed (original) (raw)
Comparative Study
Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B
C von Eichel-Streiber et al. Mol Microbiol. 1995 Jul.
Abstract
Strain 1470 is the standard typing strain for serogroup F of Clostridium difficile containing both toxin genes, toxA-1470 and toxB-1470. A polymerase chain reaction (PCR)-based approach to the sequencing of the total toxB-1470 gene identified an open reading frame (ORF) of 7104 nucleotides. In comparison with the previously sequenced toxB of C. difficile VP10463, the toxB-1470 gene has 16 additional nucleotides, 13 within the 5'-untranslated region and three within the coding region. The M(r) of ToxB-1470 is 269,262, with an isoelectric point (IP) of 4.16. The equivalent values for ToxB are M(r) 269,709 and IP 4.13. In comparison with ToxB, ToxB-1470 differs primarily in the N-terminal region between positions 1 and 868 where 148 amino acids residues are changed. The C-terminal region between residues 869-2367 is highly conserved with only six amino acid alterations. Dot matrix comparison of ToxB-1470 with ToxA and ToxB reveals the highest homology between ToxB-1470 and ToxB. Thus ToxB-1470 did not originate from recombination between ToxA and ToxB. On cultured endothelial cells, from porcine pulmonary artery, purified ToxB-1470 is less potent than ToxB. The cytopathic effects of ToxB-1470 are indistinguishable from those caused by the lethal toxin (LT) of Clostridium sordellii, but are clearly different from the patterns observed after exposure of endothelial cells to ToxA and ToxB of C. difficile (VPI10463) or alpha-toxin (Tcn alpha) of Clostridium novyi. The LT-like action of ToxB-1470 was not due to altered internalization processes, as microinjection and addition to the medium induced identical effects on the cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B.
von Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J, Sauerborn M. von Eichel-Streiber C, et al. Med Microbiol Immunol. 1990;179(5):271-9. doi: 10.1007/BF00192465. Med Microbiol Immunol. 1990. PMID: 2082160 - A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C. difficile toxin B and C. sordellii lethal toxin.
Bette P, Oksche A, Mauler F, von Eichel-Streiber C, Popoff MR, Habermann E. Bette P, et al. Toxicon. 1991;29(7):877-87. doi: 10.1016/0041-0101(91)90224-f. Toxicon. 1991. PMID: 1926186 - Cloning and characterization of the cytotoxin L-encoding gene of Clostridium sordellii: homology with Clostridium difficile cytotoxin B.
Green GA, Schué V, Monteil H. Green GA, et al. Gene. 1995 Aug 8;161(1):57-61. doi: 10.1016/0378-1119(95)00263-6. Gene. 1995. PMID: 7642137 - Comparative sequence analysis of the Clostridium difficile toxins A and B.
von Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J, Sauerborn M. von Eichel-Streiber C, et al. Mol Gen Genet. 1992 May;233(1-2):260-8. doi: 10.1007/BF00587587. Mol Gen Genet. 1992. PMID: 1603068 - Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
Barbieri JT. Barbieri JT. Int J Med Microbiol. 2000 Oct;290(4-5):381-7. doi: 10.1016/S1438-4221(00)80047-8. Int J Med Microbiol. 2000. PMID: 11111915 Review.
Cited by
- Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology.
Pan Z, Zhang Y, Luo J, Li D, Zhou Y, He L, Yang Q, Dong M, Tao L. Pan Z, et al. PLoS Pathog. 2021 Jan 28;17(1):e1009197. doi: 10.1371/journal.ppat.1009197. eCollection 2021 Jan. PLoS Pathog. 2021. PMID: 33507919 Free PMC article. - Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.
Maynard-Smith M, Ahern H, McGlashan J, Nugent P, Ling R, Denton H, Coxon R, Landon J, Roberts A, Shone C. Maynard-Smith M, et al. Vaccine. 2014 Feb 3;32(6):700-5. doi: 10.1016/j.vaccine.2013.11.099. Epub 2013 Dec 14. Vaccine. 2014. PMID: 24342251 Free PMC article. - Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB.
Lanis JM, Heinlen LD, James JA, Ballard JD. Lanis JM, et al. PLoS Pathog. 2013;9(8):e1003523. doi: 10.1371/journal.ppat.1003523. Epub 2013 Aug 1. PLoS Pathog. 2013. PMID: 23935501 Free PMC article. - Toward a structural understanding of Clostridium difficile toxins A and B.
Pruitt RN, Lacy DB. Pruitt RN, et al. Front Cell Infect Microbiol. 2012 Mar 16;2:28. doi: 10.3389/fcimb.2012.00028. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 22919620 Free PMC article. Review. - Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.
Lanis JM, Barua S, Ballard JD. Lanis JM, et al. PLoS Pathog. 2010 Aug 19;6(8):e1001061. doi: 10.1371/journal.ppat.1001061. PLoS Pathog. 2010. PMID: 20808849 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources